Dr. Reddy's Laboratories Files Form 6-K

Ticker: RDY · Form: 6-K · Filed: Oct 21, 2024 · CIK: 1135951

Sentiment: neutral

Topics: reporting, foreign-private-issuer, sec-filing

TL;DR

DRL filed a 6-K on 10/21/24, standard foreign issuer report.

AI Summary

Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 21, 2024, to report information as a foreign private issuer. The filing is in accordance with Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company is based in Hyderabad, Telangana, India, and its principal executive office is located at 8-2-337, Road No. 3, Banjara Hills.

Why It Matters

This filing indicates ongoing reporting requirements for Dr. Reddy's Laboratories as a foreign private issuer, providing transparency to investors about its regulatory compliance.

Risk Assessment

Risk Level: low — This filing is a routine disclosure for a foreign private issuer and does not contain new material financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K filing is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country or to stock exchanges on which it is listed.

What is the filing date of this Form 6-K?

The filing date of this Form 6-K is October 21, 2024.

Where is Dr. Reddy's Laboratories Ltd. headquartered?

Dr. Reddy's Laboratories Ltd. is headquartered in Hyderabad, Telangana, India, with its principal executive office at 8-2-337, Road No. 3, Banjara Hills.

Does this filing indicate Dr. Reddy's is submitting its annual report under Form 20-F?

The filing indicates that the registrant files or will file annual reports under cover of Form 20-F, as indicated by a checkmark next to 'Form 20-F'.

What is the SEC file number for Dr. Reddy's Laboratories Ltd.?

The SEC file number for Dr. Reddy's Laboratories Ltd. is 1-15182.

Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-10-21 10:09:24

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: October 21, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing